Publication: Can we afford to overlook the cost of avoidable complications in type 2 diabetes: a health economic analysis to evaluate what is the 'cost of not' acting in Turkey?
| dc.contributor.coauthor | Solorzano, J. | |
| dc.contributor.coauthor | Mihajlovi, C. J. | |
| dc.contributor.coauthor | Dinc, M. | |
| dc.contributor.coauthor | Erdogan, A. | |
| dc.contributor.department | School of Medicine | |
| dc.contributor.facultymember | Yes | |
| dc.contributor.kuauthor | Deyneli, Oğuzhan | |
| dc.contributor.schoolcollegeinstitute | SCHOOL OF MEDICINE | |
| dc.date.accessioned | 2024-11-09T23:59:33Z | |
| dc.date.issued | 2022 | |
| dc.description.fulltext | No | |
| dc.description.harvestedfrom | Manual | |
| dc.description.indexedby | WOS | |
| dc.description.openaccess | NO | |
| dc.description.peerreviewstatus | N/A | |
| dc.description.publisherscope | International | |
| dc.description.readpublish | N/A | |
| dc.description.sponsoredbyTubitakEu | N/A | |
| dc.description.studentonlypublication | No | |
| dc.description.studentpublication | No | |
| dc.description.version | N/A | |
| dc.identifier.WoSQuartile | Q1 | |
| dc.identifier.doi | 10.1016/j.jval.2022.09.301 | |
| dc.identifier.eissn | 1524-4733 | |
| dc.identifier.embargo | N/A | |
| dc.identifier.endpage | S62 | |
| dc.identifier.issn | 1098-3015 | |
| dc.identifier.issue | 12 | |
| dc.identifier.startpage | S62 | |
| dc.identifier.uri | https://doi.org/10.1016/j.jval.2022.09.301 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.14288/15659 | |
| dc.identifier.volume | 25 | |
| dc.identifier.wos | 000897594900271 | |
| dc.keywords | Type 2 diabetes | |
| dc.keywords | Avoidable complications | |
| dc.keywords | Health economic analysis | |
| dc.language.iso | eng | |
| dc.publisher | Elsevier | |
| dc.relation.affiliation | Koç University | |
| dc.relation.collection | Koç University Institutional Repository | |
| dc.relation.ispartof | Value in Health | |
| dc.relation.openaccess | N/A | |
| dc.rights | N/A | |
| dc.subject | Economics | |
| dc.subject | Health care sciences and services | |
| dc.subject | Health policy | |
| dc.title | Can we afford to overlook the cost of avoidable complications in type 2 diabetes: a health economic analysis to evaluate what is the 'cost of not' acting in Turkey? | |
| dc.type | Meeting Abstract | |
| dspace.entity.type | Publication | |
| relation.isOrgUnitOfPublication | d02929e1-2a70-44f0-ae17-7819f587bedd | |
| relation.isOrgUnitOfPublication.latestForDiscovery | d02929e1-2a70-44f0-ae17-7819f587bedd | |
| relation.isParentOrgUnitOfPublication | 17f2dc8e-6e54-4fa8-b5e0-d6415123a93e | |
| relation.isParentOrgUnitOfPublication.latestForDiscovery | 17f2dc8e-6e54-4fa8-b5e0-d6415123a93e |
